PNPLA6 Antikörper (AA 345-493) (Biotin)
Kurzübersicht für PNPLA6 Antikörper (AA 345-493) (Biotin) (ABIN7161407)
Target
Alle PNPLA6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 345-493
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Neuropathy target esterase protein (345-493AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PNPLA6 (Patatin-Like phospholipase Domain Containing 6 (PNPLA6))
-
Andere Bezeichnung
- PNPLA6
-
Hintergrund
-
Background: Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy.
Aliases: EC 3.1.1.5 antibody, Neuropathy target esterase antibody, NTEMND antibody, Patatin like phospholipase domain containing 6 antibody, Patatin like phospholipase domain containing protein 6 antibody, Patatin-like phospholipase domain-containing protein 6 antibody, PLPL6_HUMAN antibody, Pnpla6 antibody, SPG39 antibody, sws antibody
-
UniProt
- Q8IY17
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-